Main > ONCOLOGY (**)



ONCOLOGY (**)'s subsections
Active Pharma. Ingredients (APIs.)
Acute Radiation Syndrome ***
BioMarker ***
Biopsy>Liquid (Diag.) ***
Biopsy>Liquid (Diag.>Companion) ***
Bladder Cancer ***
Bladder Cancer>mUC ***
Bone Cancer>OsteoSarcoma ***
Bone Marrow Transplantation ***
Bone MET>from Solid Tumors ***
Bone MET>Pain ***
Brain Cancer ***
Brain Cancer>GBM ***
Brain Cancer>GBM>Recurrent (R) *
Brain Cancer>SEGA>TSC ***
Breast Cancer ***
Breast Cancer>Benign FibroAdenoma
Breast Cancer>Companion Diagnostics
Breast Cancer>ER+ ***
Breast Cancer>ER+>HER2- ***
Breast Cancer>ER+>HER2->Lymph Node+
Breast Cancer>ER+>MET>PM ***
Breast Cancer>FGFR1 Amplified+ ***
Breast Cancer>HER2+ ***
Breast Cancer>HER2+>Adjuvant ***
Breast Cancer>HER2+>MET ***
Breast Cancer>HER2/neu+ ***
Breast Cancer>Hereditary ***
Breast Cancer>HR+>HER2+>MET>PM *
Breast Cancer>HR+>HER2->MET ***
Breast Cancer>HR+>HER2->MET>PM *
Breast Cancer>HR+>MET ***
Breast Cancer>HR+>PM ***
Breast Cancer>MET ***
Breast Cancer>MET Bone Dis ***
Breast Cancer>MET>HER2->gBRCA->*
Breast Cancer>PR+ ***
Carcinoid Syndrome ***
Carcinoid Syndrome Diarrhea ***
Cell Therapy ***
Cervical Cancer ***
ChemoTherapy (CT) ***
Clinical Trial Patient Matching **
Colon Cancer ***
Colon Cancer>AdenoCarcinoma *
Colon Cancer>Dukes C (Stage III) *
Colon Cancer>MET ***
Colon Cancer>MET>KRAS+ ***
Colon Cancer>MET>MSI-H *
Colon Cancer>MET>NRAS+ ***
Companion DIAG. Solid Tumors *
DoxoRubicin.HCl [PENDANT (P)]
Drug Delivery ***
Drug Discovery ***
Exosomes ***
Eye Cancer>Uveal Melanoma ***
Gastric Cancer ***
Gastric Cancer>Adenocarcinoma ***
Gastric Cancer>c-MET Amplified+ ***
Gastric Cancer>MET or R ***
Gastric Cancer>MET or R PD-L1+***
GastroIntestinal Stromal Tum (P)
GEJ Cancer MET or R PD-L1+ ***
Gene Delivery ***
Gene Mutation ***
Head & Neck>Cancer ***
Head & Neck>Cancer>MET ***
Head & Neck>Cancer>R or> ***
Head & Neck>Squamous>Cancer ***
HyperCalcemia ***
ImmunoTherapy ***
Information Web-Site ***
Kidney Cancer>RCC ***
Kidney Cancer>RCC>MET ***
Kidney Cancer>RCC>PostSurgery>R ***
Leukemia>Eosinophilic>Chronic ***
Leukemia>Hairy Cell Leukemia>R/R*>
Leukemia>Lymphoblastic>Acute ***
Leukemia>Lymphoblastic>Acute>Ph+***
Leukemia>Lymphoblastic>Acute>Ph-***
Leukemia>Lymphoblastic>Acute>R/R***
Leukemia>Lymphocytic>Chronic ***
Leukemia>Lymphocytic>Chronic>HCT>
Leukemia>Lymphocytic>Chronic>MRD *
Leukemia>Lymphocytic>Chronic>R ***
Leukemia>Lymphocytic>Chronic>R/R>**
Leukemia>Mast Cell ***
Leukemia>Myeloid>Acute>CD33+***
Leukemia>Myeloid>Acute>FLT3+ ***
Leukemia>Myeloid>Acute>IDH1+ R/R
Leukemia>Myeloid>Acute>IDH2+ R/R*
Leukemia>Myeloid>Acute>R Free ***
Leukemia>Myeloid>Acute>t-AML or> *
Leukemia>Myeloid>Chronic ***
Leukemia>Myeloid>Chronic>Ph+ *
Leukemia>ProMyelocytic>Acute>R***
Liver Cancer ***
Lung>Cancer>Diagnostics ***
Lung>NSCLC ***
Lung>NSCLC>EGFR+>MET>***
Lung>NSCLC>EndoBronchial *
Lung>NSCLC>MET+> ***
Lung>NSCLC>MET>ALK(+) or ROS1(+) *
Lung>NSCLC>MET>ALK+ ***
Lung>NSCLC>MET>PD-L1+>> ***
Lung>NSCLC>MET>With BRAF V600E>***
Lung>NSCLC>Non-Squamous>MET EGFR->+
Lung>NSCLC>Non-Squamous>MET or R***
Lung>NSCLC>RET Fusions+ *
Lung>NSCLC>Squamous>MET>
Lung>SCLC>MET>Pt CT &>***
LymphEdema ***
Lymphoma>HL>Classical> ***
Lymphoma>HL>Classical>auto-HSCT>R**
Lymphoma>NHL>Auto. Transplant.***
Lymphoma>NHL>B-Cell>DLBCL R/R***
Lymphoma>NHL>B-Cell>DLBCL***
Lymphoma>NHL>B-Cell>FL ***
Lymphoma>NHL>B-Cell>FL R ***
Lymphoma>NHL>B-Cell>FL R/R CD20+***
Lymphoma>NHL>B-Cell>FL R/R>***
Lymphoma>NHL>B-Cell>Indolent>R***
Lymphoma>NHL>B-Cell>MCL R ***
Lymphoma>NHL>B-Cell>MCL***
Lymphoma>NHL>B-Cell>MZL R/R***
Lymphoma>NHL>B-Cell>PMBCL R/R*
Lymphoma>NHL>B-Cell>R/R ***
Lymphoma>NHL>B-Cell>SLL>R/R>
Lymphoma>NHL>B-Cell>WM>+***
Lymphoma>NHL>T-Cell>CTCL ***
Lymphoma>NHL>T-Cell>CTCL R ***
Lymphoma>NHL>T-Cell>CTCL>CD30+ *
Lymphoma>NHL>T-Cell>CTCL>MF/SS>R/R*
Lymphoma>NHL>T-Cell>PTCL ***
Lymphoma>NHL>T-Cell>PTCL R/R *
Lymphoma>NHL>T-Cell>sALCL ***
Lymphoma>NHL>T-Cell>sALCL>R ***
Lymphomatous Meningitis ***
Mastocytosis (PreCancerous) ***
Mucositis>Oral ***
Multiple Myeloma R/R ***
Multiple Myeloma***
Multiple Myeloma>Auto. Transplant *
Multiple Myeloma>Newly Diagnosed *
Multiple Myeloma>SRE Prevention***
MyeloDysplastic Syndromes ***
MyeloFibrosis ***
MyeloProliferative Neoplasms ***
NanoTechnology ***
NET *
NET MET or *
NET MET SR+ *
NET Paraganglioma MET UnResect.
NET Pheochromocytoma MET UnResect.
NET SR+ *
NeuroBlastoma *
Oral Cancer *
Ovarian Cancer *
Ovarian Cancer MET BRCA+ *
Ovarian Cancer MET Pt-Sensitive *
Ovarian Cancer MET Pt-Sensitive R *
Ovarian Cancer MET R *
Ovarian Cancer Pt-Sensitive R *
Ovarian Cancer R *
Ovarian Cancer R BRCA+ **
Ovarian Cancer Stage III or IV>+
PacliTaxel *
Pain *
Pancreas Cancer *
Pancreas Cancer>MET *
Pancreas Cancer>MET>MSI-H *
PhotoDynamic Therapy *
Prostate Cancer (See BTG Intl.)
Prostate Cancer (See Eagle Ph)
Prostate Cancer (See Theragenics)
Prostate Cancer MET *
Prostate Cancer MET AR+ *
Prostate Cancer NON-MET *
Prostate Cancer NON-MET CR *
Prostate Cancer R *
RadioTherapy * (RT)
RNA (Ribo Nucleic Acid) (***)
Robotics.
Sarcoma>Kaposi s Sarcoma>AIDS *
Sarcoma>OsteoSarcoma>Treat.>***
Sarcoma>Soft Tissue Sarcoma>MET *
Skin Cancer>DFSP>MET R *
Skin Cancer>Lymphoma>CTCL>MF*
Skin Cancer>Melanoma *
Skin Cancer>Melanoma>MET *
Skin Cancer>Melanoma>MET>BRAF+
Skin Cancer>Melanoma>MET>NRAS+ *
Skin Cancer>Merkel Cell C.>MET *
Skin Cancer>Non-Melanoma *
Software *
Spine Cancer See CONF *
Testicular Tumor>MET *
Thermal Therapy *
Thrombocytopenia *
Thyroid Cancer *
Thyroid Cancer>Anaplastic>MET>***
Thyroid Cancer>Medullary>MET *
UltraSound Therapy *
Uterus Adenocarcinoma MET *
VIPoma>Diarrhea *

ONCOLOGY (**)'s products
This section has no products